As the level of the DNA damage marker nuclear 53BP1 was significantly higher in the ADMSCs from patients with CKD (Figure 5d) and in the bone marrow MSCs from CKD mice (Figure 1k), we evaluated the upstream DNA damage response (DDR). This evidence concerns the gene TP53BP1 and chronic kidney disease.